Coya Therapeutics (COYA) Enterprise Value (2022 - 2025)
Coya Therapeutics (COYA) has disclosed Enterprise Value for 4 consecutive years, with -$46.8 million as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 22.07% to -$46.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$46.8 million through Dec 2025, down 22.07% year-over-year, with the annual reading at -$46.8 million for FY2025, 22.07% down from the prior year.
- Enterprise Value hit -$46.8 million in Q4 2025 for Coya Therapeutics, down from -$28.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$5.9 million in Q4 2022 to a low of -$46.8 million in Q4 2025.
- Historically, Enterprise Value has averaged -$27.8 million across 4 years, with a median of -$31.1 million in 2024.
- Biggest five-year swings in Enterprise Value: crashed 449.86% in 2023 and later rose 18.52% in 2025.
- Year by year, Enterprise Value stood at -$5.9 million in 2022, then plummeted by 449.86% to -$32.6 million in 2023, then fell by 17.51% to -$38.3 million in 2024, then dropped by 22.07% to -$46.8 million in 2025.
- Business Quant data shows Enterprise Value for COYA at -$46.8 million in Q4 2025, -$28.1 million in Q3 2025, and -$29.8 million in Q2 2025.